Abstract
BackgroundSTING pathway agonism has emerged as a potential therapeutic mechanism to stimulate an innate anti-tumor immune response. While in principle systemic administration of a STING agonist would have many therapeutic...
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have